Current Opinion in Pulmonary Medicine

Papers
(The TQCC of Current Opinion in Pulmonary Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis48
The persistent problem of persistent air-leaks: approach to management40
Bronchoscopic treatment of early-stage peripheral lung cancer35
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis34
Thoracic empyema: aetiology, diagnosis, treatment, and prevention34
Digital outcome measures in pulmonary clinical trials29
Home monitoring in asthma: towards digital twins29
Improving care in lung cancer surgery: a review of quality measures and evolving standards27
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis26
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?25
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?23
Group 2 pulmonary hypertension: from diagnosis to treatment23
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?22
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease22
Implementation of digital home monitoring and management of respiratory disease20
Editorial introductions19
Lung transplant referral considerations for individuals with cystic fibrosis19
Asthma in pregnancy: a review of recent literature18
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant17
Sarcoidosis and frailty: recognizing factors that foster holistic resilience16
The future of clinical trials in idiopathic pulmonary fibrosis16
Casting light on the many facets of sarcoidosis16
Considerations and clinical management of infections in sarcoidosis16
Cystic fibrosis liver disease in the post-modulator era16
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions16
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes15
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing15
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice15
Progress for all: addressing disparities in sarcoidosis14
Digital inhalers for asthma management14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis14
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens14
Tobacco treatment in the setting of lung cancer screening14
Home monitoring of coronavirus disease 2019 patients in different phases of disease14
Acute rejection post lung transplant13
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease13
What causes cough in pulmonary fibrosis, and how should we treat it?13
Imaging in peripheral bronchoscopy13
Exhaled breath analysis in interstitial lung disease12
Editorial: Are we ready for prime time?12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators12
Effectiveness and safety of coronavirus disease 2019 vaccines12
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort11
Telerehabilitation in pulmonary diseases11
Patterns of progression in non-IPF fibrotic interstitial lung disease11
Multidisciplinary care in nonmalignant central airway obstruction11
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown11
Infection control in cystic fibrosis: evolving perspectives and challenges11
Editorial: ‘What is your occupation?’: historical snippets10
Pulmonary rehabilitation in idiopathic pulmonary fibrosis10
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future10
Adenotonsillectomy: the good, the bad and the unknown10
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities10
The changing landscape of infections in the lung transplant recipient10
The association of preexisting severe asthma with COVID-19 outcomes10
Epigenetics and aging: relevance for sleep medicine10
0.26063680648804